User profiles for James V. Alvarez
James AlvarezFred Hutchinson Cancer Research Center Verified email at fredhutch.org Cited by 2830 |
[HTML][HTML] Oncogenic transformation by inhibitor-sensitive and-resistant EGFR mutants
…, TH Chen, W Feng, PA Jänne, JV Alvarez… - PLoS …, 2005 - journals.plos.org
Background Somatic mutations in the kinase domain of the epidermal growth factor receptor
tyrosine kinase gene EGFR are common in lung adenocarcinoma. The presence of …
tyrosine kinase gene EGFR are common in lung adenocarcinoma. The presence of …
Signal transducer and activator of transcription 3 is required for the oncogenic effects of non–small-cell lung cancer–associated mutations of the epidermal growth …
Somatic mutations in the epidermal growth factor receptor (EGFR) occur frequently in lung
cancer and confer sensitivity to EGFR kinase inhibitors gefitinib and erlotinib. These mutations…
cancer and confer sensitivity to EGFR kinase inhibitors gefitinib and erlotinib. These mutations…
Identification of a genetic signature of activated signal transducer and activator of transcription 3 in human tumors
JV Alvarez, PG Febbo, S Ramaswamy, M Loda… - Cancer research, 2005 - AACR
Signal transducer and activator of transcription 3 (STAT3) is a transcription factor that is
activated in diverse human tumors and may play a direct role in malignant transformation. …
activated in diverse human tumors and may play a direct role in malignant transformation. …
NRF2 activation promotes the recurrence of dormant tumour cells through regulation of redox and nucleotide metabolism
The survival and recurrence of dormant tumour cells following therapy is a leading cause of
death in patients with cancer. The metabolic properties of these cells are likely to be distinct …
death in patients with cancer. The metabolic properties of these cells are likely to be distinct …
CCL5 promotes breast cancer recurrence through macrophage recruitment in residual tumors
10.7554/eLife.43653.001 Over half of breast-cancer-related deaths are due to recurrence 5
or more years after initial diagnosis and treatment. This latency suggests that a population of …
or more years after initial diagnosis and treatment. This latency suggests that a population of …
[PDF][PDF] Par-4 downregulation promotes breast cancer recurrence by preventing multinucleation following targeted therapy
JV Alvarez, T Pan, J Ruth, Y Feng, A Zhou, D Pant… - Cancer cell, 2013 - cell.com
Most deaths from breast cancer result from tumor recurrence, but mechanisms underlying
tumor relapse are largely unknown. We now report that Par-4 is downregulated during tumor …
tumor relapse are largely unknown. We now report that Par-4 is downregulated during tumor …
Genome-wide analysis of STAT target genes: elucidating the mechanism of STAT-mediated oncogenesis
JV Alvarez, DA Frank - Cancer biology & therapy, 2004 - Taylor & Francis
Inappropriate activation of transcription factors is a common event in cancer. These transcription
factors contribute to a malignant phenotype by regulating genes involved in cellular …
factors contribute to a malignant phenotype by regulating genes involved in cellular …
Autocrine prolactin induced by the Pten–Akt pathway is required for lactation initiation and provides a direct link between the Akt and Stat5 pathways
…, GK Belka, ND Horseman, JV Alvarez… - Genes & …, 2012 - genesdev.cshlp.org
Extrapituitary prolactin (Prl) is produced in humans and rodents; however, little is known
about its in vivo regulation or physiological function. We now report that autocrine prolactin is …
about its in vivo regulation or physiological function. We now report that autocrine prolactin is …
DDR2 upregulation confers ferroptosis susceptibility of recurrent breast tumors through the Hippo pathway
Recurrent breast cancer presents significant challenges with aggressive phenotypes and
treatment resistance. Therefore, novel therapeutics are urgently needed. Here, we report that …
treatment resistance. Therefore, novel therapeutics are urgently needed. Here, we report that …
Oncogene pathway activation in mammary tumors dictates FDG-PET uptake
JV Alvarez, GK Belka, TC Pan, CC Chen… - Cancer research, 2014 - AACR
Increased glucose utilization is a hallmark of human cancer that is used to image tumors
clinically. In this widely used application, glucose uptake by tumors is monitored by positron …
clinically. In this widely used application, glucose uptake by tumors is monitored by positron …